Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETEPLIRSEN for Muscular dystrophy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 100 adverse event reports in the FDA FAERS database where ETEPLIRSEN was used for Muscular dystrophy.

Most Reported Side Effects for ETEPLIRSEN

Side Effect Reports % Deaths Hosp.
Product dose omission issue 641 30.8% 0 26
No adverse event 503 24.2% 0 0
Intentional dose omission 259 12.5% 1 2
Poor venous access 162 7.8% 0 3
Device issue 156 7.5% 1 2
Pyrexia 85 4.1% 2 10
Covid-19 83 4.0% 2 15
Malaise 56 2.7% 1 8
Cough 53 2.6% 3 5
Fall 53 2.6% 4 21
Pneumonia 51 2.5% 3 48
Influenza 42 2.0% 1 9
Product dose omission 41 2.0% 1 8
Exposure to sars-cov-2 36 1.7% 0 0
Illness 35 1.7% 0 2

Other Indications for ETEPLIRSEN

Duchenne muscular dystrophy (1,399) Product used for unknown indication (562)

Other Drugs Used for Muscular dystrophy

DEFLAZACORT (1,542) CASIMERSEN (17) GOLODIRSEN (15) GIVINOSTAT (11) CELECOXIB (9) PREDNISONE (8) FENTANYL (7) PREGABALIN (7) RISDIPLAM (7) METHOTREXATE (6)

Related Pages

ETEPLIRSEN Full Profile All Muscular dystrophy Drugs ETEPLIRSEN Demographics ETEPLIRSEN Timeline